Osteonecrosis due to drugs, unspecified ankle
ICD-10 M87.173 is a billable code used to indicate a diagnosis of osteonecrosis due to drugs, unspecified ankle.
Osteonecrosis, also known as avascular necrosis, is a condition characterized by the death of bone tissue due to a lack of blood supply. In the case of M87.173, the osteonecrosis is specifically attributed to drug use, which can include corticosteroids, chemotherapy agents, and other medications that may compromise blood flow to the bone. The ankle is an important weight-bearing joint, and osteonecrosis in this area can lead to significant pain, limited mobility, and potential joint collapse. Patients may present with symptoms such as localized pain, swelling, and difficulty bearing weight. Diagnosis typically involves imaging studies such as X-rays or MRI to assess the extent of bone damage. Treatment options may include conservative management with pain relief and physical therapy, or surgical interventions such as core decompression or joint replacement in more severe cases. Understanding the underlying cause of osteonecrosis is crucial for effective management and prevention of further complications.
Detailed history of medication use, imaging results, and treatment plans.
Patients presenting with ankle pain after corticosteroid therapy or chemotherapy.
Ensure clear documentation of the relationship between drug use and osteonecrosis.
Comprehensive medication history, including duration and dosage of drugs that may cause osteonecrosis.
Patients with autoimmune diseases requiring long-term corticosteroid treatment.
Monitor for signs of osteonecrosis in patients on high-dose steroids.
Used for pain management in patients with osteonecrosis.
Document indication for the procedure and any imaging findings.
Orthopedic specialists may perform this procedure for symptomatic relief.
Corticosteroids, bisphosphonates, and certain chemotherapy agents are commonly associated with osteonecrosis. It is important to document any relevant medication history when coding.
